18-HEM-12-PC (PCYC-1140-IM) A Randomized, Double-Blind Phase 3 Study of ibrutinib in Combination With Corticosteroids versus Placebo in Combination With Corticosteroids in Subjects with New Onset Chronic Graft Versus Host Disease (cGVHD)

Grants and Contracts Details

StatusFinished
Effective start/end date8/15/18 → 3/26/20

Funding

  • AbbVie Incorporated: $16,325.00